Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Therapeutic plasma exchange rapidly improves cardiac allograft function in patients with presumed antibody-mediated rejection.

Singh N, Vanlandingham S, Halverson C, Marques MB, Tallaj J, Kirklin J, Adamski J.

J Clin Apher. 2014 Dec;29(6):316-21. doi: 10.1002/jca.21338. Epub 2014 May 30.

PMID:
24891048
2.

Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.

Clerkin KJ, Farr MA, Restaino SW, Zorn E, Latif F, Vasilescu ER, Marboe CC, Colombo PC, Mancini DM.

J Heart Lung Transplant. 2017 May;36(5):540-545. doi: 10.1016/j.healun.2016.10.016. Epub 2016 Nov 17.

3.

Measurement of donor-specific HLA antibodies following plasma exchange therapy predicts clinical outcome in pediatric heart and lung transplant recipients with antibody-mediated rejection.

Jackups R Jr, Canter C, Sweet SC, Mohanakumar T, Morris GP.

J Clin Apher. 2013 Aug;28(4):301-8. doi: 10.1002/jca.21270. Epub 2013 Feb 21.

PMID:
23426730
4.

Therapeutic apheresis in transplantation medicine, experience with cardiac and lung transplantation in Jena.

Rummler S, Maier K, Barz D.

Atheroscler Suppl. 2013 Jan;14(1):33-8. doi: 10.1016/j.atherosclerosissup.2012.10.032.

PMID:
23357138
5.

Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival.

Ho EK, Vlad G, Vasilescu ER, de la Torre L, Colovai AI, Burke E, Deng M, Schwartz J, Marboe C, Mancini D, Opelz G, Suciu-Foca N.

Hum Immunol. 2011 Jan;72(1):5-10. doi: 10.1016/j.humimm.2010.10.013. Epub 2010 Nov 10.

PMID:
20971146
6.

Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.

Asante-Korang A, Jacobs JP, Ringewald J, Carapellucci J, Rosenberg K, McKenna D, McCormack J, Wilmot I, Gjeldum A, Lopez-Cepero M, Sleasman J.

Cardiol Young. 2011 Dec;21 Suppl 2:124-32. doi: 10.1017/S1047951111001703. Review.

PMID:
22152539
7.

The role of donor-specific antibodies in acute cardiac allograft dysfunction in the absence of cellular rejection.

Fine NM, Daly RC, Shankar N, Park SJ, Kushwaha SS, Gandhi MJ, Pereira NL.

Transplantation. 2014 Jul 27;98(2):229-38. doi: 10.1097/TP.0000000000000047.

8.

Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant.

Everitt MD, Hammond ME, Snow GL, Stehlik J, Revelo MP, Miller DV, Kaza AK, Budge D, Alharethi R, Molina KM, Kfoury AG.

J Heart Lung Transplant. 2012 Jul;31(7):686-93. doi: 10.1016/j.healun.2012.03.009. Epub 2012 May 1.

PMID:
22551931
10.

Role of C1q complement fixing antibody assay in therapeutic plasma exchange management of pediatric cardiac antibody mediated rejection.

Onwuemene OA, Heath DM, Hartman C, Wong ECC.

J Clin Apher. 2017 Aug;32(4):279-281. doi: 10.1002/jca.21488. Epub 2016 Jul 31.

PMID:
27475847
11.

Late Failing Heart Allografts: Pathology of Cardiac Allograft Vasculopathy and Association With Antibody-Mediated Rejection.

Loupy A, Toquet C, Rouvier P, Beuscart T, Bories MC, Varnous S, Guillemain R, Pattier S, Suberbielle C, Leprince P, Lefaucheur C, Jouven X, Bruneval P, Duong Van Huyen JP.

Am J Transplant. 2016 Jan;16(1):111-20. doi: 10.1111/ajt.13529. Epub 2015 Nov 20.

12.

Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action.

Jordan SC, Quartel AW, Czer LS, Admon D, Chen G, Fishbein MC, Schwieger J, Steiner RW, Davis C, Tyan DB.

Transplantation. 1998 Sep 27;66(6):800-5.

PMID:
9771846
13.

Therapeutic plasma exchange for the treatment of anti-NMDA receptor encephalitis.

Pham HP, Daniel-Johnson JA, Stotler BA, Stephens H, Schwartz J.

J Clin Apher. 2011 Dec;26(6):320-5. doi: 10.1002/jca.20311. Epub 2011 Sep 5.

PMID:
21898576
14.

Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti-N-methyl-D-aspartate receptor antibody encephalitis: A retrospective review.

DeSena AD, Noland DK, Matevosyan K, King K, Phillips L, Qureshi SS, Greenberg BM, Graves D.

J Clin Apher. 2015 Aug;30(4):212-6. doi: 10.1002/jca.21363. Epub 2015 Feb 9.

PMID:
25664728
15.

Therapeutic plasma exchange performed in parallel with extra corporeal membrane oxygenation for antibody mediated rejection after heart transplantation.

Jhang J, Middlesworth W, Shaw R, Charette K, Papa J, Jefferson R, Torloni AS, Schwartz J.

J Clin Apher. 2007;22(6):333-8.

PMID:
18080271
16.

Distribution and declines in cardiac allograft radionuclide left ventricular ejection fractions in relation to late mortality.

Hershberger RE, Ni H, Toy W, Wilson RA.

J Heart Lung Transplant. 2001 Apr;20(4):417-24.

PMID:
11295579
17.

Granulocyte colony-stimulating factor therapy is associated with a reduced incidence of acute rejection episodes or allograft vasculopathy in heart transplant recipients.

Vrtovec B, Haddad F, Pham M, Deuse T, Fearon WF, Schrepfer S, Leon S, Vu T, Valantine H, Hunt SA.

Transplant Proc. 2013 Jul-Aug;45(6):2406-9. doi: 10.1016/j.transproceed.2013.01.106.

PMID:
23953556
18.

Antibody-mediated rejection and treatment in pediatric patients: one center's experience.

Gulleroglu K, Baskin E, Bayrakci US, Turan M, Ozdemir BH, Moray G, Karakayali H, Haberal M.

Exp Clin Transplant. 2013 Oct;11(5):404-7.

19.

Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.

Fisher PE, Suciu-Foca N, Ho E, Michler RE, Rose EA, Mancini D.

J Heart Lung Transplant. 1995 Nov-Dec;14(6 Pt 1):1156-61.

PMID:
8719463
20.

Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression.

McNamara D, Di Salvo T, Mathier M, Keck S, Semigran M, Dec GW.

J Heart Lung Transplant. 1996 May;15(5):506-15.

PMID:
8771506

Supplemental Content

Support Center